Biomarkers of Autoimmunity and Beta Cell Metabolism in Type 1 Diabetes
Overview
Affiliations
Posttranslational protein modifications (PTMs) are an inherent response to physiological changes causing altered protein structure and potentially modulating important biological functions of the modified protein. Besides cellular metabolic pathways that may be dictated by PTMs, the subtle change of proteins also may provoke immune attack in numerous autoimmune diseases. Type 1 diabetes (T1D) is a chronic autoimmune disease destroying insulin-producing beta cells within the pancreatic islets, a result of tissue inflammation to specific autoantigens. This review summarizes how PTMs arise and the potential pathological consequence of PTMs, with particular focus on specific autoimmunity to pancreatic beta cells and cellular metabolic dysfunction in T1D. Moreover, we review PTM-associated biomarkers in the prediction, diagnosis and in monitoring disease activity in T1D. Finally, we will discuss potential preventive and therapeutic approaches of targeting PTMs in repairing or restoring normal metabolic pathways in pancreatic islets.
Identification of unique cell type responses in pancreatic islets to stress.
Maestas M, Ishahak M, Augsornworawat P, Veronese-Paniagua D, Maxwell K, Velazco-Cruz L Nat Commun. 2024; 15(1):5567.
PMID: 38956087 PMC: 11220140. DOI: 10.1038/s41467-024-49724-w.
Natural isoaspartyl protein modification of ZAP70 alters T cell responses in lupus.
Yang M, Lam T, Kanyo J, Kang I, Zhou Z, Clarke S Autoimmunity. 2023; 56(1):2282945.
PMID: 37994408 PMC: 10897934. DOI: 10.1080/08916934.2023.2282945.
Exploration of Immune Targets for Type 1 Diabetes and Latent Autoimmune Disease Immunotherapy.
Siddiqui K, Nawaz S Immunotargets Ther. 2023; 12:91-103.
PMID: 37795196 PMC: 10546931. DOI: 10.2147/ITT.S417917.
Identification of Autoantibodies to a Hybrid Insulin Peptide in Type 1 Diabetes.
Wenzlau J, Gu Y, Michels A, Rewers M, Haskins K, Yu L Diagnostics (Basel). 2023; 13(17).
PMID: 37685398 PMC: 10487141. DOI: 10.3390/diagnostics13172859.
Corral-Pujol M, Arpa B, Rosell-Mases E, Egia-Mendikute L, Mora C, Stratmann T Front Endocrinol (Lausanne). 2023; 14:1176566.
PMID: 37334284 PMC: 10272810. DOI: 10.3389/fendo.2023.1176566.